Technical Analysis for DRMA - Dermata Therapeutics, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Wide Bands | Range Expansion | 0.00% | |
Up 3 Days in a Row | Strength | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 5.94% | |
Stochastic Buy Signal | Bullish | 5.94% | |
Narrow Range Bar | Range Contraction | 5.94% | |
Inside Day | Range Contraction | 5.94% | |
Wide Bands | Range Expansion | 5.94% | |
Oversold Stochastic | Weakness | 5.94% | |
Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 11.37% |
Alert | Time |
---|---|
Possible NR7 | 1 day ago |
10 DMA Resistance | 1 day ago |
Rose Above Previous Day's High | 1 day ago |
Rose Above 10 DMA | 1 day ago |
Down 3% | 1 day ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/16/2024
Dermata Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the treatment of medical and aesthetic skin conditions. Its lead product candidate is DMT310, a once-weekly topical product that is under clinical development for the treatment of acne vulgaris, psoriasis vulgaris, and papulopustular rosacea. The company was founded in 2014 and is headquartered in San Diego, California.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Organ Systems Dermatology Psoriasis Acne Rosacea Skin Acne Vulgaris Cutaneous Conditions
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Organ Systems Dermatology Psoriasis Acne Rosacea Skin Acne Vulgaris Cutaneous Conditions
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 31.3485 |
52 Week Low | 3.24 |
Average Volume | 19,736 |
200-Day Moving Average | 9.33 |
50-Day Moving Average | 5.09 |
20-Day Moving Average | 4.36 |
10-Day Moving Average | 3.60 |
Average True Range | 0.56 |
RSI (14) | 39.02 |
ADX | 22.33 |
+DI | 21.83 |
-DI | 11.06 |
Chandelier Exit (Long, 3 ATRs) | 4.48 |
Chandelier Exit (Short, 3 ATRs) | 4.93 |
Upper Bollinger Bands | 5.95 |
Lower Bollinger Band | 2.77 |
Percent B (%b) | 0.34 |
BandWidth | 73.08 |
MACD Line | -0.49 |
MACD Signal Line | -0.44 |
MACD Histogram | -0.0423 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 4.48 | ||||
Resistance 3 (R3) | 4.44 | 4.18 | 4.37 | ||
Resistance 2 (R2) | 4.18 | 4.01 | 4.20 | 4.34 | |
Resistance 1 (R1) | 4.01 | 3.91 | 4.09 | 4.05 | 4.30 |
Pivot Point | 3.75 | 3.75 | 3.79 | 3.77 | 3.75 |
Support 1 (S1) | 3.58 | 3.58 | 3.66 | 3.62 | 3.37 |
Support 2 (S2) | 3.32 | 3.48 | 3.34 | 3.33 | |
Support 3 (S3) | 3.15 | 3.32 | 3.30 | ||
Support 4 (S4) | 3.19 |